arrow
S

Stephanie Kroeze

Cantonal Hospital Aarau
H指数:25
被引数:1,816

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors

ESMO-ESTRO关于将放射治疗与CDK4/6、HER2、PARP或mTOR抑制剂联合应用的安全性共识声明

2025-12-110
OAAI
ESMO-ESTRO framework for assessing the interactions and safety of combining radiotherapy with targeted cancer therapies or immunotherapy

ESMO-ESTRO评估放射治疗与靶向癌症治疗或免疫治疗联合应用相互作用及安全性的框架

2025-07-010
PRE
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer

寡转移去势敏感性前列腺癌转移导向治疗联合或不联合雄激素阻断治疗的多机构分析

2024-12-010
OA
Better Oncological Outcomes After Prostate-specific Membrane Antigen Positron Emission Tomography–guided Salvage Radiotherapy Following Prostatectomy

前列腺切除术后的前列腺特异性膜抗原正电子发射断层扫描引导的挽救性放射治疗可带来更好的肿瘤学结局

2024-11-270
OAAI
A Machine Learning Approach for Predicting Biochemical OutcomeAfter PSMA-PET-Guided Salvage Radiotherapy in RecurrentProstate Cancer After Radical Prostatectomy: Retrospective Study
2024-09-200
OA
Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis
2024-06-283
OAAI
European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy
2024-05-010
OAAI
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty
2023-10-0114
OA
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy
2023-09-226
OAAI
Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study

挽救性放疗对psma-pet阴性生化复发患者有效-回顾性研究的结果

2023-07-0111
PRE
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml
2023-03-115
OAAI
Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After Prostatectomy
2022-08-0121
PRE
Combining 68Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study

联合68Ga-PSMA-PET/CT导向和选择性放射治疗可改善少流前列腺癌的预后: 一项回顾性多中心研究

2021-05-1010
OAAI
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen Deprivation
2021-03-0128
PREAI
Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database
2021-01-0620
OAAI